Is TYRA stock safe? | Glauxie AI

Q: Is TYRA stock safe?

Tyra Biosciences, Inc. (TYRA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Todd Harris. Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product... Employees: 740,000.

Q: What are the risks of investing in TYRA?

Identify key risks of investing in TYRA — debt, competition, volatility, and sector headwinds.

Q: Is TYRA a good long-term investment?

Evaluate TYRA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does TYRA have?

Review TYRA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is TYRA stock safe?

🦉

Tyra Biosciences, Inc. (TYRA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOTodd Harris

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the...

Key Executives

Name	Title
Alan Fuhrman	Chief Financial Officer
Ali D. Fawaz	General Counsel & Secretary
Bhavesh Ashar	Chief Operating Officer
Daniel Bensen	Co-Founder & Chief Discovery Officer
Douglas Warner	Chief Medical Officer
Erik Goluboff	Senior Vice President of Clinical Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TYRA Profile Financials

What are the risks of investing in TYRA? Is TYRA a good long-term investment? How much debt does TYRA have?